Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (2020) Vol. 139, pp. 43-50
Open Access | Times Cited: 318

Showing 1-25 of 318 citing articles:

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Erin Bange, Nicholas Han, Paul Wileyto, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1280-1289
Open Access | Times Cited: 444
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
Amir Massarweh, Noa Eliakim‐Raz, Amos Stemmer, et al.
JAMA Oncology (2021) Vol. 7, Iss. 8, pp. 1133-1133
Open Access | Times Cited: 275
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 629-646
Open Access | Times Cited: 257
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Cancer Discovery (2020) Vol. 11, Iss. 2, pp. 233-236
Open Access | Times Cited: 205
Severity of COVID-19 in patients with lung cancer: evidence and challenges
Antonio Passaro, Christine M. Bestvina, Maria Velez Velez, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e002266-e002266
Open Access | Times Cited: 121
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
Sheena Mukkada, Nickhill Bhakta, Guillermo Chantada, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 10, pp. 1416-1426
Open Access | Times Cited: 121
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
Noha Sharafeldin, Benjamin Bates, Qianqian Song, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2232-2246
Open Access | Times Cited: 119
Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy
Astha Thakkar, Kith Pradhan, Shawn Jindal, et al.
Nature Cancer (2021) Vol. 2, Iss. 4, pp. 392-399
Open Access | Times Cited: 101
Association of COVID-19 with Comorbidities: An Update
Sayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 3, pp. 334-354
Open Access | Times Cited: 53
Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties
Constance D. Lehman, Helen Anne D’Alessandro, Dexter P. Mendoza, et al.
Journal of the American College of Radiology (2021) Vol. 18, Iss. 6, pp. 843-852
Open Access | Times Cited: 95
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott T.C. Shepherd, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1321-1337
Open Access | Times Cited: 82
Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study
Hassan Alwafi, Abdallah Y. Naser, Sultan Qanash, et al.
Journal of Multidisciplinary Healthcare (2021) Vol. Volume 14, pp. 839-852
Open Access | Times Cited: 81
Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19
Anna Brodziak, Dawid Sigorski, Małgorzata Osmola, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 411-411
Open Access | Times Cited: 76
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
David J. Chung, Gunjan L. Shah, Sean M. Devlin, et al.
Blood Cancer Discovery (2021) Vol. 2, Iss. 6, pp. 568-576
Open Access | Times Cited: 70
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Chiara Corti, Gabriele Antonarelli, Florian Scotté, et al.
Annals of Oncology (2021) Vol. 33, Iss. 2, pp. 158-168
Open Access | Times Cited: 70
Clinical presentations and outcomes of children with cancer and COVID‐19: A systematic review
Jagdish Prasad Meena, Aditya Gupta, Pranay Tanwar, et al.
Pediatric Blood & Cancer (2021) Vol. 68, Iss. 6
Open Access | Times Cited: 65
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
Son Tran, Tony H. Truong, Aru Narendran
European Journal of Cancer (2021) Vol. 159, pp. 259-274
Open Access | Times Cited: 65
SARS-CoV-2 vaccines for cancer patients: a call to action
Chiara Corti, Edoardo Crimini, Paolo Tarantino, et al.
European Journal of Cancer (2021) Vol. 148, pp. 316-327
Open Access | Times Cited: 63
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis
Marco Tagliamento, Elisa Agostinetto, Marco Bruzzone, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 163, pp. 103365-103365
Open Access | Times Cited: 60
Neutrophil Extracellular Traps in Colorectal Cancer Progression and Metastasis
Umama Khan, Sabrina Chowdhury, Md Morsaline Billah, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7260-7260
Open Access | Times Cited: 60
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
Peter D. Smits, Samuel Gratzl, Michael Simonov, et al.
Vaccine (2023) Vol. 41, Iss. 15, pp. 2447-2455
Open Access | Times Cited: 31
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches
Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 334-334
Open Access | Times Cited: 28
COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
Alfred Chung Pui So, Harriet McGrath, Jonathan Y. Ting, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3573-3573
Open Access | Times Cited: 52
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology
Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, et al.
JCO Global Oncology (2021), Iss. 7, pp. 162-172
Open Access | Times Cited: 48
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
David J. Pinato, Lorenza Scotti, Alessandra Gennari, et al.
European Journal of Cancer (2021) Vol. 150, pp. 190-202
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top